Millennium Management’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-510
| Closed | -$6.52K | – | 5824 |
|
|
2025
Q4 | $6.52K | Buy |
+510
| New | +$7.85K | ﹤0.01% | 5885 |
|
|
2025
Q1 | – | Sell |
-1,664
| Closed | -$30.3K | – | 5949 |
|
|
2024
Q4 | $30.3K | Buy |
+1,664
| New | +$32.7K | ﹤0.01% | 5665 |
|
|
2024
Q3 | – | Sell |
-997
| Closed | -$14K | – | 6155 |
|
|
2024
Q2 | $14K | Sell |
997
-795
| -44% | -$13.8K | ﹤0.01% | 5574 |
|
|
2024
Q1 | $34.1K | Sell |
1,792
-464
| -21% | -$9.03K | ﹤0.01% | 5747 |
|
|
2023
Q4 | $50.1K | Sell |
2,256
-5,997
| -73% | -$178K | ﹤0.01% | 5472 |
|
|
2023
Q3 | $310K | Sell |
8,253
-1,166
| -12% | -$66.9K | ﹤0.01% | 4917 |
|
|
2023
Q2 | $676K | Sell |
9,419
-508
| -5% | -$32.1K | ﹤0.01% | 4331 |
|
|
2023
Q1 | $669K | Sell |
9,927
-1,148
| -10% | -$68.9K | ﹤0.01% | 4418 |
|
|
2022
Q4 | $343K | Sell |
11,075
-1,990
| -15% | -$59K | ﹤0.01% | 4999 |
|
|
2022
Q3 | $355K | Sell |
13,065
-13,168
| -50% | -$514K | ﹤0.01% | 5236 |
|
|
2022
Q2 | $1.15M | Buy |
+26,233
| New | +$1.2M | ﹤0.01% | 4242 |
|
|
2022
Q1 | – | Sell |
-1,526
| Closed | -$128K | – | 6987 |
|
|
2021
Q4 | $128K | Sell |
1,526
-600
| -28% | -$67.3K | ﹤0.01% | 6152 |
|
|
2021
Q3 | $345K | Sell |
2,126
-486
| -19% | -$79K | ﹤0.01% | 5706 |
|
|
2021
Q2 | $394K | Buy |
+2,612
| New | +$440K | ﹤0.01% | 5496 |
|
|
2020
Q4 | – | Sell |
-6,547
| Closed | -$1.04M | – | 5248 |
|
|
2020
Q3 | $1.04M | Buy |
+6,547
| New | +$1.18M | ﹤0.01% | 3099 |
|
|
2020
Q2 | – | Sell |
-2,273
| Closed | -$351K | – | 4220 |
|
|
2020
Q1 | $351K | Buy |
+2,273
| New | +$229K | ﹤0.01% | 3087 |
|
|
2019
Q2 | – | Sell |
-4,911
| Closed | -$744K | – | 4102 |
|
|
2019
Q1 | $744K | Buy |
+4,911
| New | +$765K | ﹤0.01% | 3033 |
|
|
2018
Q3 | – | Sell |
-2,198
| Closed | -$501K | – | 3956 |
|
|
2018
Q2 | $501K | Sell |
2,198
-17,019
| -89% | -$3.22M | ﹤0.01% | 3165 |
|
|
2018
Q1 | $2.71M | Buy |
19,217
+11,018
| +134% | +$1.67M | ﹤0.01% | 2152 |
|
|
2017
Q4 | $1.07M | Buy |
8,199
+6,138
| +298% | +$781K | ﹤0.01% | 2664 |
|
|
2017
Q3 | $256K | Buy |
+2,061
| New | +$210K | ﹤0.01% | 3126 |
|
|
2017
Q2 | – | Sell |
-8,663
| Closed | -$780K | – | 3518 |
|
|
2017
Q1 | $780K | Buy |
8,663
+8,013
| +1,233% | +$895K | ﹤0.01% | 2540 |
|
|
2016
Q4 | $71K | Buy |
+650
| New | +$71.2K | ﹤0.01% | 3225 |
|
|
2015
Q4 | – | Sell |
-510
| Closed | -$64K | – | 3463 |
|
|
2015
Q3 | $64K | Buy |
+510
| New | +$68K | ﹤0.01% | 3321 |
|
|
2015
Q2 | – | Sell |
-2,543
| Closed | -$671K | – | 3408 |
|
|
2015
Q1 | $671K | Buy |
+2,543
| New | +$523K | ﹤0.01% | 2562 |
|
Other funds holding CTSO
CM
Millennium Management's CTSO Position: Q1 2026 in Review
Millennium Management sold out of Cytosorbents Corp (CTSO) in Q1 2026, closing a stake of 510 shares — an estimated $6.52K sold.
Millennium Management first reported a position in CTSO in Q1 2015 and held it in 25 quarters. The position peaked at $2.71M in Q1 2018. 48 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.
- Millennium Management reported no remaining Cytosorbents Corp position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 510 Cytosorbents Corp shares in Q1 2026, an estimated $6.52K.
- Millennium Management first reported a position in Cytosorbents Corp in Q1 2015 and held it in 25 quarters.
- Millennium Management's Cytosorbents Corp position peaked at $2.71M in Q1 2018.
- 48 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.